The Chinese Solar Machine Layer by Layer Fire in the Library The Mystery Behind Anesthesia
Credit: Daniel Pregibon and Patrick S. Doyle
A mix of "bar-coded" particles could detect multiple compounds at once.
By simultaneously scanning for thousands of genes or proteins in a biological sample, doctors could diagnose many diseases in a single step. But today's DNA or protein microarrays are too expensive for widespread clinical use, in part because their manufacture is a complex, multistep process.
A potentially cheaper tool for detecting telltale DNA and proteins appears on this page: capsule-shaped polymer particles, each 180 micrometers long. Each particle can be loaded with a specific biomolecule so that one half of the particle fluoresces when it detects a disease target. Imprinted with bar-code-like patterns of holes, the particles can be read optically; they could serve as detectors for more than a million distinct biological targets. Technicians with the right optical equipment could, in theory, mix the particles with a sample and read off the results.
To read the entire article you must log in:
Most of our content — all daily news, blogs, and videos — is free. Magazine stories are paid. To read this story, you must have a subscription or you must use a reading credit. Registration to Technology Review is free and entitles registrants to three free reading credits.
Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.
Our list of the 50 most innovative companies, including the following: